Cyrus Arman is a life sciences and biotechnology executive whose experience and depth of knowledge spans numerous therapeutic areas while guiding corporate development initiatives, licensing agreements, financial investments, and strategic alliances for numerous companies. Prior to CytoDyn, he served in leadership positions with several biotechnology companies, including Amgen, Neuvogen, and Nimble Therapeutics. Cyrus received his Ph.D. in neuroscience and M.S. degree in biomedical engineering from the University of Southern California, and his M.B.A from the UCLA Anderson School of Management.
.svg)
